Scientific Commons: Jason Mark White

Hyperalgesia in Opioid-Managed Chronic Pain and Opioid-Dependent Patients (2009)

Hay, Justin Luke, White, Jason Mark, Bochner, Felix, Somogyi, Andrew Alexander, Semple, Timothy James, Rousefell, Bruce

Justin L. Hay, Jason M. White, Felix Bochner, Andrew A. Somogyi, Tim J. Semple, and Bruce Rounsefell

Buprenorphine for the management of opioid withdrawal (2009)

Gowing, Linda Rosemary, Ali, Robert Leonard, White, Jason Mark

Linda Gowing, Robert Ali, Jason M. White

Hyperalgesia in Opioid-Managed Chronic Pain and Opioid-Dependent Patients (2009)

Hay, Justin Luke, White, Jason Mark, Bochner, Felix, Somogyi, Andrew Alexander, Semple, Timothy James, Rousefell, Bruce

Justin L. Hay, Jason M. White, Felix Bochner, Andrew A. Somogyi, Tim J. Semple, and Bruce Rounsefell

Buprenorphine for the management of opioid withdrawal (2009)

Gowing, Linda Rosemary, Ali, Robert Leonard, White, Jason Mark

Linda Gowing, Robert Ali, Jason M. White

Open-label dose-finding trial of buprenorphine implants (Probuphine)(R) for treatment of heroin dependence (2009)

White, Jason Mark, Bell, James Robert, Saunders, John B., Williamson, Paul Andrew, Makowska, Maria, Farquharson, Aaron Lee, ...

Jason White, James Bell, John B. Saunders, Paul Williamson, Maria Makowska, Aaron Farquharson, Katherine L. Beebe

Open-label dose-finding trial of buprenorphine implants (Probuphine)(R) for treatment of heroin dependence (2009)

White, Jason Mark, Bell, James Robert, Saunders, John B., Williamson, Paul Andrew, Makowska, Maria, Farquharson, Aaron Lee, ...

Jason White, James Bell, John B. Saunders, Paul Williamson, Maria Makowska, Aaron Farquharson, Katherine L. Beebe

Enhanced Buprenorphine Analgesia with the Addition of Ultra-low-dose Naloxone in Healthy Subjects (2008)

La Vincente, Sophie F., White, Jason Mark, Somogyi, Andrew Alexander, Bochner, Felix, Chapleo, C B.

Animal studies have demonstrated that co-administration of an ultra-low-dose opioid antagonist with an opioid agonist may result in enhanced analgesia. Investigation of this effect in humans has been...

Psychometric evaluation of the Amphetamine Cessation Symptom Assessment (2008)

McGregor, Catherine, Srisurapanont, Manit, Mitchell, Amanda Jane, Longo, Maria Cristiana, Cahill, Sharon, White, Jason Mark

Inter- and intra-subject variability in ethanol pharmacokinetic parameters: Effects of testing interval and dose (2008)

Yelland, Lisa Nicole, Burns, Jaimi Paula, Sims, Noel, Salter, Amy Beatrix, White, Jason Mark

Calculation of a blood alcohol concentration (BAC) at the time of an offence by forward or back-extrapolation, using population average values for ethanol pharmacokinetic parameters or a single...

Enhanced Buprenorphine Analgesia with the Addition of Ultra-low-dose Naloxone in Healthy Subjects (2008)

La Vincente, Sophie F., White, Jason Mark, Somogyi, Andrew Alexander, Bochner, Felix, Chapleo, C B.

Animal studies have demonstrated that co-administration of an ultra-low-dose opioid antagonist with an opioid agonist may result in enhanced analgesia. Investigation of this effect in humans has been...

Psychometric evaluation of the Amphetamine Cessation Symptom Assessment (2008)

McGregor, Catherine, Srisurapanont, Manit, Mitchell, Amanda Jane, Longo, Maria Cristiana, Cahill, Sharon, White, Jason Mark

Hotham, Elizabeth Dorothy, Ali, Robert Leonard, White, Jason Mark, Robinson, Jeffrey Samuel

Antinociceptive effects of high dose remifentanil in male methadone-maintained patients (2008)

Hay, Justin Luke, White, Jason Mark, Bochner, Felix, Somogyi, Andrew Alexander

Antinociceptive effects of high dose remifentanil in male methadone-maintained patients (2008)

Hay, Justin Luke, White, Jason Mark, Bochner, Felix, Somogyi, Andrew Alexander

Exposure to opioid maintenance treatment reduces long-term mortality (2008)

Gibson, Amy, Degenhardt, Louisa, Mattick, Richard P., Ali, Robert Leonard, White, Jason Mark, O'Brien, Susannah

Amy Gibson, Louisa Degenhardt, Richard P. Mattick, Robert Ali, Jason White & Susannah O’Brien

Flexible dosing of Tincture of Opium in the management of opioid withdrawal: pharmacokinetics and pharmacodynamics (2008)

Somogyi, Andrew Alexander, Larsen, Mie, Abadi, Reza M., Jittiwutikarn, Jaroon, Ali, Robert Leonard, White, Jason Mark

Andrew A. Somogyi, Mie Larsen, Reza M. Abadi, Jaroon Jittiwutikarn, Robert Ali & Jason M. White

Exposure to opioid maintenance treatment reduces long-term mortality (2008)

Gibson, Amy, Degenhardt, Louisa, Mattick, Richard P., Ali, Robert Leonard, White, Jason Mark, O'Brien, Susannah

Amy Gibson, Louisa Degenhardt, Richard P. Mattick, Robert Ali, Jason White & Susannah O’Brien

Flexible dosing of Tincture of Opium in the management of opioid withdrawal: pharmacokinetics and pharmacodynamics (2008)

Somogyi, Andrew Alexander, Larsen, Mie, Abadi, Reza M., Jittiwutikarn, Jaroon, Ali, Robert Leonard, White, Jason Mark

Andrew A. Somogyi, Mie Larsen, Reza M. Abadi, Jaroon Jittiwutikarn, Robert Ali & Jason M. White

Symptoms and sleep patterns during inpatient treatment of methamphetamine withdrawal: A comparison of mirtazapine and modafinil with treatment as usual (2008)

McGregor, Catherine, Srisurapanont, Manit, Mitchell, Amanda Jane, Wickes, Wendy, White, Jason Mark

Symptoms and sleep patterns during inpatient treatment of methamphetamine withdrawal: A comparison of mirtazapine and modafinil with treatment as usual (2008)

McGregor, Catherine, Srisurapanont, Manit, Mitchell, Amanda Jane, Wickes, Wendy, White, Jason Mark

Pharmacotherapy of methamphetamine addiction: an update (2008)

Elkashef, Ahmed, Vocci, Frank, Hanson, Glen, White, Jason Mark, Wickes, Wendy, Tiihonen, Jari

Abstract Methamphetamine dependence is a serious public health problem worldwide for which there are no approved pharmacological treatments. Psychotherapy is still the mainstay of treatment; however,...

Pharmacotherapy of methamphetamine addiction: an update (2008)

Elkashef, Ahmed, Vocci, Frank, Hanson, Glen, White, Jason Mark, Wickes, Wendy, Tiihonen, Jari

Abstract Methamphetamine dependence is a serious public health problem worldwide for which there are no approved pharmacological treatments. Psychotherapy is still the mainstay of treatment; however,...

Opioid maintenance: a comparative review of pharmacological strategies (2007)

White, Jason Mark, Lopatko, Olga Vlagislavovna

http://www.expertopin.com/

Opioids, pain and addiction: Cause and consequence (2007)

White, Jason Mark, Hay, Justin Luke

Jason M. White and Justin L. Hay

Opioid maintenance: a comparative review of pharmacological strategies (2007)

White, Jason Mark, Lopatko, Olga Vlagislavovna

http://www.expertopin.com/

Opioids, pain and addiction: Cause and consequence (2007)

White, Jason Mark, Hay, Justin Luke

Jason M. White and Justin L. Hay

A cost-effectiveness analysis of heroin detoxification methods in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD) (2006)

Shanahan, M. D., Doran, C. M., Digiusto, E., Bell, J., Lintzerisa, N., White, Jason Mark, ...

Abstract This economic evaluation was part of the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD) project. Data from four trials of heroin detoxification methods,...

Methadone maintenance patients are cross-tolerant to the antinociceptive effects of very high plasma morphine concentrations (2006)

Athanasos, P., Smith, C. S., White, Jason Mark, Somogyi, Andrew Alexander, Bochner, Felix, Ling, W.

Plasma drug concentrations and physiological measures in 'dance party' participants (2006)

Irvine, Rodney James, Keane, Michael, Felgate, P., McCann, U., Callaghan, P., White, Jason Mark

The increasing use of (7) 3,4-methylenedioxymethamphetamine (MDMA) in the setting of large dance parties (‘raves’) and clubs has been the source of some concern, because of potential acute...

Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal (review) (2006)

Gowing, Linda Rosemary, Ali, Robert Leonard, White, Jason Mark

The definitive version may be found at www.wiley.com

Fluctuations in (R,S)-methadone pharmacokinetics and response among long-term methadone maintenance patients (2006)

Mitchell, T. B., Dyer, Kyle R., Newcombe, David, Somogyi, Andrew Alexander, White, Jason Mark

The definitive version is available at www.blackwell-synergy.com

Switching between methadone and morphine for maintenance treatment of opioid dependence: Impact on pain sensitivity and mood status (2006)

Mitchell, T. B., White, Jason Mark, Somogyi, Andrew Alexander, Bochner, Felix

This is an electronic version of an article published in American Journal on Addictions, 2006; 15 (4):311-315. American Journal on Addictions is available online at:...

Maintenance pharmacotherapy for opioid dependence and SF-36 Health status: a comparison with general population norms and other chronic disorders (2006)

O'Brien, Susannah, Mattick, Richard P., White, Jason Mark, Breen, C., Kimber, J., Ritter, A., ...

Opioid antagonists with minimal sedation for opioid withdrawal (review) (2006)

Gowing, L. R., Ali, Robert Leonard, White, Jason Mark

A cost-effectiveness analysis of heroin detoxification methods in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD) (2006)

Shanahan, M. D., Doran, C. M., Digiusto, E., Bell, J., Lintzerisa, N., White, Jason Mark, ...

Abstract This economic evaluation was part of the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD) project. Data from four trials of heroin detoxification methods,...

Methadone maintenance patients are cross-tolerant to the antinociceptive effects of very high plasma morphine concentrations (2006)

Athanasos, P., Smith, C. S., White, Jason Mark, Somogyi, Andrew Alexander, Bochner, Felix, Ling, W.

Plasma drug concentrations and physiological measures in 'dance party' participants (2006)

Irvine, Rodney James, Keane, Michael, Felgate, P., McCann, U., Callaghan, P., White, Jason Mark

The increasing use of (7) 3,4-methylenedioxymethamphetamine (MDMA) in the setting of large dance parties (‘raves’) and clubs has been the source of some concern, because of potential acute...

Opioid antagonists under heavy sedation or anaesthesia for opioid withdrawal (review) (2006)

Gowing, Linda Rosemary, Ali, Robert Leonard, White, Jason Mark

The definitive version may be found at www.wiley.com

Fluctuations in (R,S)-methadone pharmacokinetics and response among long-term methadone maintenance patients (2006)

Mitchell, T. B., Dyer, Kyle R., Newcombe, David, Somogyi, Andrew Alexander, White, Jason Mark

The definitive version is available at www.blackwell-synergy.com

Switching between methadone and morphine for maintenance treatment of opioid dependence: Impact on pain sensitivity and mood status (2006)

Mitchell, T. B., White, Jason Mark, Somogyi, Andrew Alexander, Bochner, Felix

This is an electronic version of an article published in American Journal on Addictions, 2006; 15 (4):311-315. American Journal on Addictions is available online at:...

Maintenance pharmacotherapy for opioid dependence and SF-36 Health status: a comparison with general population norms and other chronic disorders (2006)

O'Brien, Susannah, Mattick, Richard P., White, Jason Mark, Breen, C., Kimber, J., Ritter, A., ...

Opioid antagonists with minimal sedation for opioid withdrawal (review) (2006)

Gowing, L. R., Ali, Robert Leonard, White, Jason Mark

The nature, time course and severity of methamphetamine withdrawal (2005)

McGregor, C., Srisurapanont, M., Jittiwutikarn, J., Laobhripatr, C., Wongtan, T., White, Jason Mark

The definitive version is available at www.blackwell-synergy.com

Within- and between- subject variability in methadone pharmacokinetics and pharmacodynamics in methadone maintenance subjects (2005)

Hanna, J., Foster, D. J. R., Salter, Amy Beatrix, Somogyi, Andrew Alexander, White, Jason Mark, Bochner, Felix

The definitive version is available at www.blackwell-synergy.com

Spider bites: Addressing mythology and poor evidence (2005)

Isbister, Geoffrey K., White, Jason Mark, Currie, Bart J., Bush, Steven, Vetter, R. S., Warrell, David

The nature, time course and severity of methamphetamine withdrawal (2005)

McGregor, C., Srisurapanont, M., Jittiwutikarn, J., Laobhripatr, C., Wongtan, T., White, Jason Mark

The definitive version is available at www.blackwell-synergy.com

Within- and between- subject variability in methadone pharmacokinetics and pharmacodynamics in methadone maintenance subjects (2005)

Hanna, J., Foster, D. J. R., Salter, Amy Beatrix, Somogyi, Andrew Alexander, White, Jason Mark, Bochner, Felix

The definitive version is available at www.blackwell-synergy.com

Spider bites: Addressing mythology and poor evidence (2005)

Isbister, Geoffrey K., White, Jason Mark, Currie, Bart J., Bush, Steven, Vetter, R. S., Warrell, David

Slow-release oral morphine versus methadone: a crossover comparison of patient outcomes and acceptability as maintenance pharmacotherapies for opioid dependence (2004)

Mitchell, T. B., White, Jason Mark, Somogyi, Andrew Alexander, Bochner, Felix

The definitive version is available at www.blackwell-synergy.com

Pleasure into pain: the consequences of long-term opioid use (2004)

White, Jason Mark

One consequence of repeated drug administration is the development of adaptations in the nervous system, sometimes termed ‘drug-opposite’ responses. During administration, the effects of the drug...

Changes in methadone concentration, opiod effects, and opioid withdrawal during induction onto maintenance treatment (2004)

Athanasos, P., Morrish, G. A., Somogyi, Andrew Alexander, Bochner, Felix, White, Jason Mark

Comparison of tincture of opium and methadone to control opioid withdrawal in a Thai treatment centre (2004)

Jittiwutikarn, J., Ali, Robert Leonard, White, Jason Mark, Bochner, Felix, Somogyi, Andrew Alexander, Foster, D. J.R.

The definitive version is available at www.blackwell-synergy.com

Population pharmacokinetics of (R)-, (S)- and rac-methadone in methadone maintenance patients (2004)

Foster, D. J.R., Somogyi, Andrew Alexander, White, Jason Mark, Bochner, Felix

The definitive version is available at www.blackwell-synergy.com.

Subjective and physiological responses among racemic-methadone maintenance patients in relation to relative (S)- vs. (R)-methadone exposure (2004)

Mitchell, T. B., Dyer, K. R., Newcombe, D. A. L., Salter, Amy Beatrix, Somogyi, Andrew Alexander, Bochner, Felix, ...

The definitive version is available at www.blackwell-synergy.com

Baclofen prevents MDMA-induced rise in core body temperature in rats (2004)

Bexis, S., Phillis, B. D., Ong, J., White, Jason Mark, Irvine, Rodney James

A number of deaths have been attributed to severe hyperthermia resulting from the ingestion of 3,4-methylenedioxymethamphetamine (MDMA). The mechanisms underlying these events are unclear. In an...

Evaluation of levo-alpha-acetylmethdol (LAAM) as an alternative treatment for methadone maintenance patients who regularly experience withdrawal: a pharmacokinetic and pharmacodynamic analysis (2004)

Newcombe, D. A.L., Bochner, Felix, White, Jason Mark, Somogyi, Andrew Alexander

The aim of this study was to determine if substitution of daily methadone with second daily levo-alpha-acetylmethadol (LAAM) would convert non-holders on methadone into holders on LAAM, and to...

Use of radiotelemetry to evaluate respiratory depression produced by chronic methadone administration (2004)

Lewanowitsch, Tanya, White, Jason Mark, Irvine, Rodney James

Slow-release oral morphine versus methadone: a crossover comparison of patient outcomes and acceptability as maintenance pharmacotherapies for opioid dependence (2004)

Mitchell, T. B., White, Jason Mark, Somogyi, Andrew Alexander, Bochner, Felix

The definitive version is available at www.blackwell-synergy.com

Pleasure into pain: the consequences of long-term opioid use (2004)

White, Jason Mark

One consequence of repeated drug administration is the development of adaptations in the nervous system, sometimes termed ‘drug-opposite’ responses. During administration, the effects of the drug...

Changes in methadone concentration, opiod effects, and opioid withdrawal during induction onto maintenance treatment (2004)

Athanasos, P., Morrish, G. A., Somogyi, Andrew Alexander, Bochner, Felix, White, Jason Mark

Comparison of tincture of opium and methadone to control opioid withdrawal in a Thai treatment centre (2004)

Jittiwutikarn, J., Ali, Robert Leonard, White, Jason Mark, Bochner, Felix, Somogyi, Andrew Alexander, Foster, D. J.R.

The definitive version is available at www.blackwell-synergy.com

Population pharmacokinetics of (R)-, (S)- and rac-methadone in methadone maintenance patients (2004)

Foster, D. J.R., Somogyi, Andrew Alexander, White, Jason Mark, Bochner, Felix

The definitive version is available at www.blackwell-synergy.com.

Subjective and physiological responses among racemic-methadone maintenance patients in relation to relative (S)- vs. (R)-methadone exposure (2004)

Mitchell, T. B., Dyer, K. R., Newcombe, D. A. L., Salter, Amy Beatrix, Somogyi, Andrew Alexander, Bochner, Felix, ...

The definitive version is available at www.blackwell-synergy.com

Baclofen prevents MDMA-induced rise in core body temperature in rats (2004)

Bexis, S., Phillis, B. D., Ong, J., White, Jason Mark, Irvine, Rodney James

A number of deaths have been attributed to severe hyperthermia resulting from the ingestion of 3,4-methylenedioxymethamphetamine (MDMA). The mechanisms underlying these events are unclear. In an...

Evaluation of levo-alpha-acetylmethdol (LAAM) as an alternative treatment for methadone maintenance patients who regularly experience withdrawal: a pharmacokinetic and pharmacodynamic analysis (2004)

Newcombe, D. A.L., Bochner, Felix, White, Jason Mark, Somogyi, Andrew Alexander

The aim of this study was to determine if substitution of daily methadone with second daily levo-alpha-acetylmethadol (LAAM) would convert non-holders on methadone into holders on LAAM, and to...

Use of radiotelemetry to evaluate respiratory depression produced by chronic methadone administration (2004)

Lewanowitsch, Tanya, White, Jason Mark, Irvine, Rodney James

Buprenorphine versus methadone maintenance therapy: a randomized double-blind trial with 405 opioid-dependent patients (2003)

Mattick, Richard P., Ali, Robert Leonard, White, Jason Mark, O'Brien, Susannah, Wolk, Seija, Danz, Catherine Elizabeth Maria

The definitive version is available at www.blackwell-synergy.com

Opioid effects and opioid withdrawal during a 24 h dosing interval in patients maintained on buprenorphine (2003)

Lopatko, O. V., White, Jason Mark, Huber, A., Ling, W.

In maintenance patients methadone has been shown to produce considerable changes in opioid effects and withdrawal over the dosing interval. As a partial agonist buprenorphine may be expected to...

Buprenorphine versus methadone maintenance: a cost-effectiveness analysis (2003)

Doran, C. M., Shanahan, M., Mattick, R. P., Ali, Robert Leonard, White, Jason Mark, Bell, J.

This article presents the cost-effectiveness results of a randomised controlled trial conducted in two Australian cities. The trial was designed to assess the safety, efficacy and cost-effectiveness...

Comparative pharmacodynamics and pharmacokinetics of methadone and slow-release oral morphine for maintenance treatment of opioid dependence (2003)

Mitchell, T. B., White, Jason Mark, Somogyi, Andrew Alexander, Bochner, Felix

BACKGROUND: Slow-release oral morphine (SROM) has been proposed as an alternative maintenance pharmacotherapy to methadone for treatment of opioid dependence. However, the pharmacodynamics and...

Antagonist-precipitated heroin withdrawal under anaesthetic prior to maintenance naltrexone treatment: determinants of withdrawal severity (2003)

Ali, Robert Leonard, Thomas, P. D., White, Jason Mark, Gregor, C Mc, Danz, C. E.M., Gowing, L. R., ...

This study sought to characterize antagonist-precipitated heroin withdrawal during and immediately following anaesthesia and to identify the determinants of withdrawal severity and duration in 48...

In-patient benzodiazepine withdrawal: comparison of fixed and symptom-triggered taper methods (2003)

Gregor, C Mc, Machin, A., White, Jason Mark

This is an electronic version of an article published in Drug and Alcohol Review, 2003; 22 (2):175-180. Drug and Alcohol Review is available online at:...

Buprenorphine versus methadone maintenance therapy: a randomized double-blind trial with 405 opioid-dependent patients (2003)

Mattick, Richard P., Ali, Robert Leonard, White, Jason Mark, O'Brien, Susannah, Wolk, Seija, Danz, Catherine Elizabeth Maria

The definitive version is available at www.blackwell-synergy.com

Opioid effects and opioid withdrawal during a 24 h dosing interval in patients maintained on buprenorphine (2003)

Lopatko, O. V., White, Jason Mark, Huber, A., Ling, W.

In maintenance patients methadone has been shown to produce considerable changes in opioid effects and withdrawal over the dosing interval. As a partial agonist buprenorphine may be expected to...

Buprenorphine versus methadone maintenance: a cost-effectiveness analysis (2003)

Doran, C. M., Shanahan, M., Mattick, R. P., Ali, Robert Leonard, White, Jason Mark, Bell, J.

This article presents the cost-effectiveness results of a randomised controlled trial conducted in two Australian cities. The trial was designed to assess the safety, efficacy and cost-effectiveness...

Comparative pharmacodynamics and pharmacokinetics of methadone and slow-release oral morphine for maintenance treatment of opioid dependence (2003)

Mitchell, T. B., White, Jason Mark, Somogyi, Andrew Alexander, Bochner, Felix

BACKGROUND: Slow-release oral morphine (SROM) has been proposed as an alternative maintenance pharmacotherapy to methadone for treatment of opioid dependence. However, the pharmacodynamics and...

Antagonist-precipitated heroin withdrawal under anaesthetic prior to maintenance naltrexone treatment: determinants of withdrawal severity (2003)

Ali, Robert Leonard, Thomas, P. D., White, Jason Mark, Gregor, C Mc, Danz, C. E.M., Gowing, L. R., ...

This study sought to characterize antagonist-precipitated heroin withdrawal during and immediately following anaesthesia and to identify the determinants of withdrawal severity and duration in 48...

In-patient benzodiazepine withdrawal: comparison of fixed and symptom-triggered taper methods (2003)

Gregor, C Mc, Machin, A., White, Jason Mark

This is an electronic version of an article published in Drug and Alcohol Review, 2003; 22 (2):175-180. Drug and Alcohol Review is available online at:...

?+G438-Adrenergic agonists in opioid withdrawal (2002)

Gowing, L. R., Farrell, M., Ali, Robert Leonard, White, Jason Mark

The definitive version is available at www.blackwell-synergy.com

In vivo and in vitro potency studies of 6b-naltrexol, the major human metabolite of naltrexone (2002)

Porter, S. J., Somogyi, Andrew Alexander, White, Jason Mark

A comparison of antagonist-precipitated withdrawal under anesthesia to standard inpatient withdrawal as a precursor to maintenance naltrexone treatment in heroin users: outcomes at 6 and 12 months (2002)

McGregor, C., Ali, Robert Leonard, White, Jason Mark, Thomas, P. D., Gowing, L. R.

Relationship between LAAM-methadone preference and treatment outcomes (2002)

White, Jason Mark, Danz, C., Kneebone, J., La Vincente, S. F., Newcombe, D. A., Ali, Robert Leonard

Which substitution pharmacotherapy is most effective in treating opioid dependence? (2002)

Gowing, Linda Rosemary, Ali, Robert Leonard, White, Jason Mark

The document attached has been archived with permission from the editor of the Medical Journal of Australia. An external link to the publisher’s copy is included.

The contribution of the metabolite p-hydroxyamphetamine to the central actions of p-methoxyamphetamine (2002)

Kaminskas, L. M., Irvine, Rodney James, Callaghan, Paul, White, Jason Mark, Kirkbride, K. P.

The original publication is available at www.springerlink.com

Reply to Dr. Clark's comment on Doverty et al., hyperalgesic responses in methadone maintenance patients (Pain 2001;90 : 91-96) (2002)

Doverty, Mark, White, Jason Mark, Somogyi, Andrew Alexander, Bochner, Felix, Ali, Robert Leonard, Ling, Walter

?+G438-Adrenergic agonists in opioid withdrawal (2002)

Gowing, L. R., Farrell, M., Ali, Robert Leonard, White, Jason Mark

The definitive version is available at www.blackwell-synergy.com

In vivo and in vitro potency studies of 6b-naltrexol, the major human metabolite of naltrexone (2002)

Porter, S. J., Somogyi, Andrew Alexander, White, Jason Mark

A comparison of antagonist-precipitated withdrawal under anesthesia to standard inpatient withdrawal as a precursor to maintenance naltrexone treatment in heroin users: outcomes at 6 and 12 months (2002)

McGregor, C., Ali, Robert Leonard, White, Jason Mark, Thomas, P. D., Gowing, L. R.

Relationship between LAAM-methadone preference and treatment outcomes (2002)

White, Jason Mark, Danz, C., Kneebone, J., La Vincente, S. F., Newcombe, D. A., Ali, Robert Leonard

Which substitution pharmacotherapy is most effective in treating opioid dependence? (2002)

Gowing, Linda Rosemary, Ali, Robert Leonard, White, Jason Mark

The document attached has been archived with permission from the editor of the Medical Journal of Australia. An external link to the publisher’s copy is included.

The contribution of the metabolite p-hydroxyamphetamine to the central actions of p-methoxyamphetamine (2002)

Kaminskas, L. M., Irvine, Rodney James, Callaghan, Paul, White, Jason Mark, Kirkbride, K. P.

The original publication is available at www.springerlink.com

Reply to Dr. Clark's comment on Doverty et al., hyperalgesic responses in methadone maintenance patients (Pain 2001;90 : 91-96) (2002)

Doverty, Mark, White, Jason Mark, Somogyi, Andrew Alexander, Bochner, Felix, Ali, Robert Leonard, Ling, Walter

Precipitated withdrawal following codeine administration is dependent on CYP genotype (2001)

Chew, M., White, Jason Mark, Somogyi, Andrew Alexander, Bochner, Felix, Irvine, Rodney James

The relationship between mood state and plasma methadone concentration in maintenance patients (2001)

Dyer, K. R., White, Jason Mark, Foster, D. J. R., Bochner, Felix, Menelaou, A., Somogyi, Andrew Alexander

The relationship between blood benzodiazepine concentration and vehicle crash culpability (2001)

Longo, M. C., Lokan, R. J., White, Jason Mark

Attenuation of morphine withdrawal signs by the GABAB receptor agonist baclofen (2001)

Bexis, S., Ong, J., White, Jason Mark

Abstract The present study examined the effect of the γ-aminobutyric acidB (GABAB) receptor agonist, baclofen on naloxone-induced withdrawal signs in morphine-dependent rats and modification by the...

The acute effects of zolpidem compared to diazepam and lorazepam using radiotelemetry (2001)

Elliott, E. E., White, Jason Mark

The present study used a radiotelemetric method to compare the muscle relaxant, hypothermic and locomotor depressant actions of the imidazopyridine zolpidem, with those of the benzodiazepines...

Hyperalgesic responses in methadone maintenance patients (2001)

Doverty, Mark, White, Jason Mark, Somogyi, Andrew Alexander, Bochner, Felix, Ali, Robert Leonard, Ling, W.

Methadone maintenance patients are cross-tolerant to the antinociceptive effects of morphine (2001)

Doverty, M., Somogyi, Andrew Alexander, White, Jason Mark, Bochner, Felix, Beare, Christopher Hudson, Menelaou, A., ...

Modification of d-amphetamine-induced responses by baclofen in rats (2001)

Phillis, B. D., Ong, J., White, Jason Mark, Bonnielle, Claudia.

The original publication is available at www.springerlink.com

Precipitated withdrawal following codeine administration is dependent on CYP genotype (2001)

Chew, M., White, Jason Mark, Somogyi, Andrew Alexander, Bochner, Felix, Irvine, Rodney James

The relationship between mood state and plasma methadone concentration in maintenance patients (2001)

Dyer, K. R., White, Jason Mark, Foster, D. J. R., Bochner, Felix, Menelaou, A., Somogyi, Andrew Alexander

The relationship between blood benzodiazepine concentration and vehicle crash culpability (2001)

Longo, M. C., Lokan, R. J., White, Jason Mark

Attenuation of morphine withdrawal signs by the GABAB receptor agonist baclofen (2001)

Bexis, S., Ong, J., White, Jason Mark

Abstract The present study examined the effect of the γ-aminobutyric acidB (GABAB) receptor agonist, baclofen on naloxone-induced withdrawal signs in morphine-dependent rats and modification by the...

The acute effects of zolpidem compared to diazepam and lorazepam using radiotelemetry (2001)

Elliott, E. E., White, Jason Mark

The present study used a radiotelemetric method to compare the muscle relaxant, hypothermic and locomotor depressant actions of the imidazopyridine zolpidem, with those of the benzodiazepines...

Hyperalgesic responses in methadone maintenance patients (2001)

Doverty, Mark, White, Jason Mark, Somogyi, Andrew Alexander, Bochner, Felix, Ali, Robert Leonard, Ling, W.

Methadone maintenance patients are cross-tolerant to the antinociceptive effects of morphine (2001)

Doverty, M., Somogyi, Andrew Alexander, White, Jason Mark, Bochner, Felix, Beare, Christopher Hudson, Menelaou, A., ...

Modification of d-amphetamine-induced responses by baclofen in rats (2001)

Phillis, B. D., Ong, J., White, Jason Mark, Bonnielle, Claudia.

The original publication is available at www.springerlink.com

Opioid antagonists and adrenergic agonists for the management of opioid withdrawal (2000)

Gowing, Linda Rosemary, Ali, Robert Leonard, White, Jason Mark

The definitive version may be found at www.wiley.com

Buprenorphine for the management of opioid withdrawal (Cochrane review) (2000)

Gowing, Linda Rosemary, Ali, Robert Leonard, White, Jason Mark

Opioid antagonists and adrenergic agonists for the management of opioid withdrawal (2000)

Gowing, Linda Rosemary, Ali, Robert Leonard, White, Jason Mark

The definitive version may be found at www.wiley.com

Buprenorphine for the management of opioid withdrawal (Cochrane review) (2000)

Gowing, Linda Rosemary, Ali, Robert Leonard, White, Jason Mark

Jason Mark White

Publication List Details